• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国队列中早产儿视网膜病变(ROP)风险筛查工具的评估

Evaluation of a Risk Screening Tool for Retinopathy of Prematurity (ROP) in a German Cohort.

作者信息

Butt N, Chlad P, Bläser A, Pulzer F, Thome U H, Ackermann B W

机构信息

Department of Neonatology, Leipzig University, Leipzig, Germany.

Department of Ophthalmology, Leipzig University, Leipzig, Germany.

出版信息

Ophthalmic Epidemiol. 2025 Aug;32(4):455-463. doi: 10.1080/09286586.2024.2399346. Epub 2024 Dec 18.

DOI:10.1080/09286586.2024.2399346
PMID:39693580
Abstract

PURPOSE

To assess the efficacy of the DIGIROP-Birth algorithm in identifying infants at risk for developing retinopathy of prematurity (ROP).

METHODS

In a retrospective study, we included preterm infants over 11 years, 2010-2020, meeting the inclusion criteria for the DIGIROP-Birth calculator (24 + 0/7 to 30 + 6/7 weeks of gestational age). We assessed the validity of DIGIROP-Birth using receiver-operating characteristic (ROC) curves and calculated area-under-curve (AUC), sensitivity, specificity, and positive and negative predictive values.

RESULTS

897 infants were included in the analysis. The median age of the first ophthalmological examination was 40 days (IQR 32-50), the median gestational age was 198 days (IQR 185-209; corresponding to 28 + 2/7 gestational weeks), median birth weight was 1000 g (IQR 790-1300). Of 897 screened children, 458 (51.1%) were diagnosed with ROP, and 34 of 897 (3.8%) required treatment.Analysis of ROP requiring treatment predicted by DIGIROP showed an AUC of 0.860 [95%-CI 0.795-0.925]. An equilibrium of sensitivity and specificity existed at a probability of 4.12%. The positive predictive value was 10.95%, and the negative predictive value was 99.36%. Independent significant peri- and postnatal risk factors were emergency cesarean section and mass blood transfusions.

CONCLUSIONS

The DIGIROP-Birth calculator showed good predictive power in our studied population, with an incidence of 3.79% for therapy-requiring ROP. Peri- and postnatal risk factors should be included in ROP screening.

摘要

目的

评估DIGIROP-Birth算法在识别有发生早产儿视网膜病变(ROP)风险的婴儿方面的有效性。

方法

在一项回顾性研究中,我们纳入了2010年至2020年期间超过11岁的早产儿,这些早产儿符合DIGIROP-Birth计算器的纳入标准(胎龄24+0/7至30+6/7周)。我们使用受试者操作特征(ROC)曲线评估DIGIROP-Birth的有效性,并计算曲线下面积(AUC)、敏感性、特异性以及阳性和阴性预测值。

结果

897名婴儿纳入分析。首次眼科检查的中位年龄为40天(四分位间距32-50),中位胎龄为198天(四分位间距185-209;相当于28+2/7孕周),中位出生体重为1000克(四分位间距790-1300)。在897名筛查儿童中,458名(51.1%)被诊断为ROP,897名中有34名(3.8%)需要治疗。对DIGIROP预测的需要治疗的ROP分析显示AUC为0.860[95%置信区间0.795-0.925]。在概率为4.12%时存在敏感性和特异性的平衡。阳性预测值为10.95%,阴性预测值为99.36%。独立的围产期和产后显著风险因素是急诊剖宫产和大量输血。

结论

DIGIROP-Birth计算器在我们的研究人群中显示出良好的预测能力,需要治疗的ROP发生率为3.79%。围产期和产后风险因素应纳入ROP筛查。

相似文献

1
Evaluation of a Risk Screening Tool for Retinopathy of Prematurity (ROP) in a German Cohort.德国队列中早产儿视网膜病变(ROP)风险筛查工具的评估
Ophthalmic Epidemiol. 2025 Aug;32(4):455-463. doi: 10.1080/09286586.2024.2399346. Epub 2024 Dec 18.
2
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.早期使用促红细胞生成素预防早产和/或低出生体重儿的红细胞输血
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004863. doi: 10.1002/14651858.CD004863.pub2.
3
Higher versus lower amino acid intake in parenteral nutrition for newborn infants.新生儿肠外营养中较高与较低氨基酸摄入量的比较。
Cochrane Database Syst Rev. 2018 Mar 5;3(3):CD005949. doi: 10.1002/14651858.CD005949.pub2.
4
Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.早期与晚期使用促红细胞生成素预防早产和/或低出生体重儿红细胞输血
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004865. doi: 10.1002/14651858.CD004865.pub2.
5
Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants.针对较低与较高动脉血氧饱和度对早产儿死亡或残疾的影响。
Cochrane Database Syst Rev. 2017 Apr 11;4(4):CD011190. doi: 10.1002/14651858.CD011190.pub2.
6
Early erythropoiesis-stimulating agents in preterm or low birth weight infants.早产或低出生体重婴儿早期促红细胞生成素刺激剂
Cochrane Database Syst Rev. 2017 Nov 16;11(11):CD004863. doi: 10.1002/14651858.CD004863.pub5.
7
Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产儿和/或低出生体重儿的动脉导管未闭。
Cochrane Database Syst Rev. 2003(2):CD003481. doi: 10.1002/14651858.CD003481.
8
Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants.β受体阻滞剂用于预防和治疗早产儿视网膜病变
Cochrane Database Syst Rev. 2018 Mar 2;3(3):CD011893. doi: 10.1002/14651858.CD011893.pub2.
9
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产和/或低出生体重婴儿的动脉导管未闭。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD003481. doi: 10.1002/14651858.CD003481.pub3.
10
Validation of DIGIROP- Birth and DIGIROP- Screen for the discovery of retinopathy of prematurity requiring treatment in preterm births in Saudi Arabia.DIGIROP-出生和DIGIROP-筛查在沙特阿拉伯早产中发现需要治疗的早产儿视网膜病变的有效性验证。
Saudi Med J. 2025 Apr;46(4):345-351. doi: 10.15537/smj.2025.46.4.20240773.